Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL29207988 | 0.97 | AGXT (0.58) | AGXTCA1CA2CA9MAOB | |
| SCHEMBL12648082 | 0.93 | AGXT (0.54) | AGXTCA1CA2CA9MAOB | |
| SCHEMBL12736280 | 0.93 | AGXT (0.54) | AGXTCA1CA2CA9MAOB | |
| SCHEMBL9330223 | 0.89 | AGXT (0.50) | AGXTCA1CA2CA9MAOB | |
| SCHEMBL134443 | 0.88 | IDO1 (0.46) | AGXTMAOBIDO1 | |
| SCHEMBL12111797 | 0.87 | AGXT (0.48) | AGXTCA1CA2CA9MAOB | |
| SCHEMBL8279908 | 0.87 | MAOB (0.61) | AGXTMAOBNPC1RAB9APARP10 | |
| SCHEMBL17122445 | 0.87 | AGXT (0.48) | AGXTCA1CA2CA9MAOB | |
| SCHEMBL17738603 | 0.87 | KCNH2 (0.50) | AGXTCA1CA2CA9MAOB | |
| SCHEMBL17429497 | 0.85 | AGXT (0.47) | AGXTCA1CA2CA9MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 642 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108817049-B | Soil heavy metal treatment facility containing propulsion constriction device | 徐州工程学院 | 2021-07-23 | — | — | CN | claimed |
| CN-108906870-B | Soil heavy metal treatment facility containing temperature-sensing device | 徐州工程学院 | 2021-07-23 | — | — | CN | claimed |
| CN-108772416-B | Soil heavy metal treatment facility containing control system | 徐州工程学院 | 2021-07-16 | — | — | CN | claimed |
| US-20120288752-A1 | ADDITIVE FOR OVERCHARGE PREVENTING OF SECONDARY BATTERY AND NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY INCLUDING THE SAME | SAMSUNG CORNING PRECISION MATERIALS CO., LTD. | 2012-11-15 | — | — | US | claimed |
| EP-2523247-A1 | Additive for overcharge preventing of secondary battery and non-aqueous electrolyte for secondary battery including the same | Samsung Corning Precision Materials Co., Ltd. (KR) | 2012-11-14 | — | — | EP | claimed |
| CN-119569545-A | Preparation method of methyl ether compound of fatty alcohol | 中国人民解放军军事科学院防化研究院 | 2025-03-07 | — | — | CN | disclosed |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | ARVINAS OPERATIONS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | ARVINAS OPERATIONS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2024134657-A1 | PYRROLOPYRIDINE AND PYRROLOPYRIDAZINE BASED COMPOUNDS AND USE THEREOF AS PKR INHIBITORS | PROTEKT THERAPEUTICS LTD. (IL) | 2024-06-27 | — | — | WO | disclosed |
| US-11857519-B2 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | ARVINAS OPERATIONS, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-11857519-B2 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | ARVINAS OPERATIONS, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-11834460-B2 | Imide-based modulators of proteolysis and associated methods of use | YALE UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| EP-0234467-A2 | Electrodeless heterogeneous polypyrrole composite | The B.F. GOODRICH Company (US) | 1987-09-02 | — | — | EP | disclosed |
| US-4680236-A | Electrodeless heterogeneous polypyrrole composite | THE BF GOODRICH COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| EP-0219091-A2 | Pyran derivatives and process for their preparation | BASF Aktiengesellschaft (DE) | 1987-04-22 | — | — | EP | disclosed |
| US-4617353-A | FORMING POLYPYRROLE IN SOLUTION OF MATRIX POLYMER | THE B. F. GOODRICH COMPANY (US) | 1986-10-14 | — | — | US | disclosed |
| US-4539081-A | ELECTROCHEMICAL OXIDATION IN ALKANOL CONTAINING SULFONIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 1985-09-03 | — | — | US | disclosed |
| EP-0129795-A2 | Process for manufacturing benzaldehyde dialkylacetals | BASF Aktiengesellschaft (DE) | 1985-01-02 | — | — | EP | disclosed |
| US-4340700-A | Process for preparing a phenolic resin from an aralkylene ether and an aromatic aldehyde | ALBRIGHT & WILSON LIMITED (GB) | 1982-07-20 | — | — | US | disclosed |
| US-4113782-A | CATALYTIC OXIDATION | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | IRAK1, IRAK4, IRAK2 | AGXT 3780/4885CA1 2572/4885CA2 4367/4885 |
| US-11857519-B2 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | CRBN, MDM2, VHL | AGXT 2299/4885CA1 2650/4885CA2 4176/4885 |
| US-11834460-B2 | Imide-based modulators of proteolysis and associated methods of use | CRBN, MDM2, UBE2N | AGXT 3958/4885CA1 539/4885CA2 2225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.